Corporate Webinar – April 10, 2025
Appointment adds significant clinical and scientific expertise in the field of psychedelic-based therapies
Appointment adds significant clinical and scientific expertise in the field of psychedelic-based therapies
Appointment adds significant clinical and scientific expertise in the field of psychedelic-based therapies
Company poised to enter 2025 with cash position of $5.6 million and debt-free balance sheet